Semaglutide in patients with heart failure with reduced ejection fraction: safety and effectiveness – a target trial emulation

10/11/2025
07/09/2026
EU PAS number:
EUPAS1000000809
Study
Ongoing
Documents
Study protocol
Initial protocol
English (351.97 KB - PDF) View document
Updated protocol
English (937.28 KB - PDF) View document
Study results
Study report
Other information